Living network meta-analysis to compare nemolizumab against other available targeted systemic treatments for atopic dermatitis.

ABSTRACT:

SUBMITTER: Drucker AM 

PROVIDER: S-EPMC12360034 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature